BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36892046)

  • 21. Arrhythmia Patterns in Patients on Ibrutinib.
    Fazal M; Kapoor R; Cheng P; Rogers AJ; Narayan SM; Wang P; Witteles RM; Perino AC; Baykaner T; Rhee JW
    Front Cardiovasc Med; 2021; 8():792310. PubMed ID: 35047578
    [No Abstract]   [Full Text] [Related]  

  • 22. Spontaneous occurrence of symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia in untreated patients.
    Clair WK; Wilkinson WE; McCarthy EA; Page RL; Pritchett EL
    Circulation; 1993 Apr; 87(4):1114-22. PubMed ID: 8462140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Types and risk factors of arrhythmia on young patients with acute coronary syndrome in Henan province].
    Zhao J; He F; Hu DY; Ding RJ; Yu XJ; Gou JJ; Wang L; Zhang P; Li XB; Guo JH; Liu WL; Li CL; Li L; Gao CY; Zhao LS; Chu YJ; Huang ZW; Wei JH; Hua SH; Liu RY; Zhuang XF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Jul; 41(7):572-6. PubMed ID: 24284184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atrial arrhythmias in patients with arrhythmogenic right ventricular cardiomyopathy: Prevalence, echocardiographic predictors, and treatment.
    Cardona-Guarache R; Åström-Aneq M; Oesterle A; Asirvatham R; Svetlichnaya J; Marcus GM; Gerstenfeld EP; Klein L; Scheinman MM
    J Cardiovasc Electrophysiol; 2019 Oct; 30(10):1801-1810. PubMed ID: 31310380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac side effects of bruton tyrosine kinase (BTK) inhibitors.
    Tang CPS; McMullen J; Tam C
    Leuk Lymphoma; 2018 Jul; 59(7):1554-1564. PubMed ID: 28901789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is hospital admission for initiation of antiarrhythmic therapy with sotalol for atrial arrhythmias required? Yield of in-hospital monitoring and prediction of risk for significant arrhythmia complications.
    Chung MK; Schweikert RA; Wilkoff BL; Niebauer MJ; Pinski SL; Trohman RG; Kidwell GA; Jaeger FJ; Morant VA; Miller DP; Tchou PJ
    J Am Coll Cardiol; 1998 Jul; 32(1):169-76. PubMed ID: 9669266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia.
    Page RL; Wilkinson WE; Clair WK; McCarthy EA; Pritchett EL
    Circulation; 1994 Jan; 89(1):224-7. PubMed ID: 8281651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of radiofrequency ablation in the management of supraventricular arrhythmias: experience in 760 consecutive patients.
    Kay GN; Epstein AE; Dailey SM; Plumb VJ
    J Cardiovasc Electrophysiol; 1993 Aug; 4(4):371-89. PubMed ID: 8269306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Azimilide for the treatment of atrial fibrillation, atrial flutter, and paroxysmal supraventricular tachycardia: results of a randomized trial and insights on the concordance of symptoms and recurrent arrhythmias.
    Page RL; Pritchett EL; Connolly S; Wilkinson WE;
    J Cardiovasc Electrophysiol; 2008 Feb; 19(2):172-7. PubMed ID: 17916138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ibutilide for rapid conversion of atrial fibrillation or flutter in a mixed critically ill patient population.
    Delle Karth G; Schillinger M; Geppert A; Haumer M; Gwechenberger M; Meyer B; Heinz G; Siostrzonek P
    Wien Klin Wochenschr; 2005 Feb; 117(3):92-7. PubMed ID: 15773423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of 24-hour Holter monitoring with 14-day novel adhesive patch electrocardiographic monitoring.
    Barrett PM; Komatireddy R; Haaser S; Topol S; Sheard J; Encinas J; Fought AJ; Topol EJ
    Am J Med; 2014 Jan; 127(1):95.e11-7. PubMed ID: 24384108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pre and Postoperative evaluation of the incidence of arrhythmia in patients undergoing corrective intervention for Ebstein anomaly].
    Brancaccio G; Chauvaud S; Carpentier A
    Ital Heart J Suppl; 2000 Sep; 1(9):1173-9. PubMed ID: 11140286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators.
    Stambler BS; Wood MA; Ellenbogen KA; Perry KT; Wakefield LK; VanderLugt JT
    Circulation; 1996 Oct; 94(7):1613-21. PubMed ID: 8840852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bruton's tyrosine kinase Inhibitors and Cardiotoxicity: More Than Just Atrial Fibrillation.
    Sestier M; Hillis C; Fraser G; Leong D
    Curr Oncol Rep; 2021 Aug; 23(10):113. PubMed ID: 34342738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-mitochondrial M2 Antibodies Enhance the Risk of Supraventricular Arrhythmias in Patients with Elevated Hepatobiliary Enzyme Levels.
    Konishi H; Fukuzawa K; Mori S; Satomi-Kobayashi S; Kiuchi K; Suzuki A; Yano Y; Yoshida A; Hirata KI
    Intern Med; 2017; 56(14):1771-1779. PubMed ID: 28717071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Superiority of ibutilide (a new class III agent) over DL-sotalol in converting atrial flutter and atrial fibrillation. The Ibutilide/Sotalol Comparator Study Group.
    Vos MA; Golitsyn SR; Stangl K; Ruda MY; Van Wijk LV; Harry JD; Perry KT; Touboul P; Steinbeck G; Wellens HJ
    Heart; 1998 Jun; 79(6):568-75. PubMed ID: 10078083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous administration of diltiazem in the treatment of supraventricular tachyarrhythmias.
    Boudonas G; Lefkos N; Efthymiadis AP; Styliadis IG; Tsapas G
    Acta Cardiol; 1995; 50(2):125-34. PubMed ID: 7610735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Real-world treatment patterns, discontinuation and clinical outcomes in patients with B-cell lymphoproliferative diseases treated with BTK inhibitors in China.
    Yan Y; Lv R; Wang T; Yu Y; Huang Y; Xiong W; Li Y; Sui W; Wang Q; Huang W; An G; Zou D; Wang J; Qiu L; Yi S
    Front Immunol; 2023; 14():1184395. PubMed ID: 37483630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Management of Supraventricular Tachyarrhythmias in Patients with Pulmonary Arterial Hypertension.
    Małaczyńska-Rajpold K; Komosa A; Błaszyk K; Araszkiewicz A; Janus M; Olasińska-Wiśniewska A; Jankiewicz S; Mączyński M; Mularek-Kubzdela T
    Heart Lung Circ; 2016 May; 25(5):442-50. PubMed ID: 26643289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New-onset arrhythmia associated with patients hospitalized for thyroid dysfunction.
    Doshi R; Dhawan T; Rendon C; Rodriguez MA; Nutakki K; Gianopulos J; Desai R; Vallabhajosyula S; Adalja D; Patel P; Gullapalli N
    Heart Lung; 2020; 49(6):758-762. PubMed ID: 32979641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.